EBOS-OWNED healthcare communications agency Zest has announced digital medication management company MedAdvisor as its "preferred technology partner" in a move to help increase medication adherence, reduce hospital readmissions and provide better continuity of care for patients.
The announcement follows the move in late Oct by Zest's parent company, EBOS Group Limited, to take a 14.1% stake in MedAdvisor.
As part of the $10.5 million strategic investment, MedAdvisor signed a Memorandum of Understanding (MOU) with Zest where the parties agreed to work together on strategic opportunities, including in relation to the Zest Connect Pharmacy Network.
MedAdvisor now boasts more than 2,600 Australian pharmacies and connecting around 6 million patients, with nearly 1 million connected digitally.
The above article was sent to subscribers in Pharmacy Daily's issue from 07 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 07 Dec 17
